(16015810), N. J., (16015813), K. R. C., (14958336), H. H. M., (14942629), S. R., (16015816), C. T., (15038249), C. A. W., . . . (14942641), R. O. H. (2025). Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Chicagoスタイル(17版)引用形式(16015810), Noor Jailkhani, et al. Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.
MLA(9版)引用形式(16015810), Noor Jailkhani, et al. Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.